HRP20070094T3 - NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI - Google Patents

NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Info

Publication number
HRP20070094T3
HRP20070094T3 HR20070094T HRP20070094T HRP20070094T3 HR P20070094 T3 HRP20070094 T3 HR P20070094T3 HR 20070094 T HR20070094 T HR 20070094T HR P20070094 T HRP20070094 T HR P20070094T HR P20070094 T3 HRP20070094 T3 HR P20070094T3
Authority
HR
Croatia
Prior art keywords
optionally substituted
hydrogen
6alkyl
groups
hydroxy
Prior art date
Application number
HR20070094T
Other languages
English (en)
Croatian (hr)
Inventor
Alihodzic Sulejman
Michael Berge John
Lewis Jarvest Richard
Original Assignee
Glaxo Group Limited
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0310962A external-priority patent/GB0310962D0/en
Priority claimed from GB0407391A external-priority patent/GB0407391D0/en
Application filed by Glaxo Group Limited, Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxo Group Limited
Publication of HRP20070094T3 publication Critical patent/HRP20070094T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20070094T 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI HRP20070094T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0310962A GB0310962D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0407391A GB0407391D0 (en) 2004-03-31 2004-03-31 Novel compounds
PCT/EP2004/005083 WO2004101587A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 memberred-ring compounds

Publications (1)

Publication Number Publication Date
HRP20070094T3 true HRP20070094T3 (hr) 2008-05-31

Family

ID=33454579

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070094T HRP20070094T3 (hr) 2003-05-13 2004-05-11 NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI

Country Status (15)

Country Link
US (1) US20070293472A1 (enExample)
EP (1) EP1628989B1 (enExample)
JP (1) JP2006528667A (enExample)
AR (1) AR044304A1 (enExample)
AT (1) ATE348837T1 (enExample)
CA (1) CA2525455A1 (enExample)
CL (1) CL2004001012A1 (enExample)
DE (1) DE602004003809T2 (enExample)
DK (1) DK1628989T3 (enExample)
ES (1) ES2278319T3 (enExample)
HR (1) HRP20070094T3 (enExample)
PL (1) PL1628989T3 (enExample)
PT (1) PT1628989E (enExample)
SI (1) SI1628989T1 (enExample)
WO (1) WO2004101587A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
MXPA06012923A (es) * 2004-05-06 2007-07-18 Glaxosmithkline Zagreb Macrolidos asociados a ester utiles para el tratamiento de infecciones microbianas.
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
PE20070802A1 (es) * 2005-11-09 2007-10-19 Glaxo Group Ltd Derivados de eritromicina 4''-sustituidos como agentes antimicrobianos
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
EP2571506B1 (en) * 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
ES2278319T3 (es) 2007-08-01
DK1628989T3 (da) 2007-10-08
SI1628989T1 (sl) 2007-06-30
EP1628989B1 (en) 2006-12-20
PL1628989T3 (pl) 2007-05-31
DE602004003809D1 (de) 2007-02-01
DE602004003809T2 (de) 2007-10-11
AR044304A1 (es) 2005-09-07
WO2004101587A1 (en) 2004-11-25
JP2006528667A (ja) 2006-12-21
CL2004001012A1 (es) 2005-03-18
CA2525455A1 (en) 2004-11-25
ATE348837T1 (de) 2007-01-15
PT1628989E (pt) 2007-03-30
US20070293472A1 (en) 2007-12-20
EP1628989A1 (en) 2006-03-01

Similar Documents

Publication Publication Date Title
HRP20070094T3 (hr) NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI
YU48088B (sh) Derivati indola
KR950704313A (ko) 5-아릴인돌 유도체 및 세로토닌(5-ht₁)작용물질로서의 그의 용도(5-arylindole derivatives and their use as serotonin(5-ht₁)agonists)
AR082994A1 (es) Derivados de pirazina como bloqueadores del canal epitelial de sodio
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
ATE286026T1 (de) Amid-derivate und deren medizinische verwendung
PE20030062A1 (es) Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
BR9103433A (pt) Derivados de 4-benzil-isoxazol
HRP20080236T3 (en) Quinoline derivatives as phosphodiesterase inhibitors
EE04310B1 (et) Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
ATE72436T1 (de) 2-(methyl(4-piperidinyl)>-1,2,3,4-tetrahydro-9h pyrido(3,4-b>indolderivate, ihre herstellung und therapeutische verwendung.
PE20001289A1 (es) Nuevos antibioticos macrolidos
AR035254A1 (es) Derivados fluorquinolonicos de oxazolidinonas utiles como antibacterianos, procedimiento para su obtencion y su utilizacion para la preparacion de una composicion farmaceutica
YU6799A (sh) Derivati tetrahidrohinolina kao antagonisti eaa
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
AR049269A1 (es) Macrolidos unidos por esteres, utiles para el tratamiento de infecciones microbianas. procesos de preparacion y composiciones farmaceuticas.
CO5611121A2 (es) Derivados de fenil amidas con silicio utiles como microbicidas
DK304289A (da) Benzenderivater
PE25998A1 (es) DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
DE69910568D1 (de) Furopyridinderivate und ihre therapeutische verwendung
AR064480A1 (es) Derivados de espiro-piperidina
AR044305A1 (es) Compuesto de macrolido de 14 y 15 miembros sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende